150 related articles for article (PubMed ID: 34869693)
1. Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study.
Menichelli D; Carnevale R; Nocella C; Cammisotto V; Castellani V; Bartimoccia S; Frati G; Pignatelli P; Pastori D
Front Cardiovasc Med; 2021; 8():779503. PubMed ID: 34869693
[No Abstract] [Full Text] [Related]
2. Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort.
Pastori D; Ettorre E; Carnevale R; Nocella C; Bartimoccia S; Del Sordo E; Cammisotto V; Violi F; Pignatelli P;
Atherosclerosis; 2019 Oct; 289():195-200. PubMed ID: 31303312
[TBL] [Abstract][Full Text] [Related]
3. Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients?
Pastori D; Carnevale R; Menichelli D; Nocella C; Bartimoccia S; Novo M; Leo I; Violi F; Pignatelli P
Antioxid Redox Signal; 2016 Nov; 25(14):751-755. PubMed ID: 27577528
[TBL] [Abstract][Full Text] [Related]
4. Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Menichelli D; Nocella C; Carnevale R; Violi F
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27609361
[TBL] [Abstract][Full Text] [Related]
5. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
[TBL] [Abstract][Full Text] [Related]
6. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study.
Menichelli D; Sciacqua A; Cangemi R; Andreozzi P; Del Sole F; Violi F; Pignatelli P; Pastori D;
Int J Clin Pract; 2021 Mar; 75(3):e13771. PubMed ID: 33078565
[TBL] [Abstract][Full Text] [Related]
8. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
9. Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events.
Carnevale R; Nocella C; Pignatelli P; Bartimoccia S; Stefanini L; Basili S; Novo M; D'Amico A; Cammisotto V; Pastori D; Violi F
Atherosclerosis; 2018 Jul; 274():29-34. PubMed ID: 29747088
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation.
Pastori D; Farcomeni A; Saliola M; Del Sole F; Pignatelli P; Violi F; Lip GYH;
Eur J Intern Med; 2018 Aug; 54():34-39. PubMed ID: 29655807
[TBL] [Abstract][Full Text] [Related]
11. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
[TBL] [Abstract][Full Text] [Related]
12. Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.
Pastori D; Carnevale R; Nocella C; Novo M; Santulli M; Cammisotto V; Menichelli D; Pignatelli P; Violi F
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584074
[TBL] [Abstract][Full Text] [Related]
13. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
[TBL] [Abstract][Full Text] [Related]
14. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation.
Ghanbari H; Başer K; Jongnarangsin K; Chugh A; Nallamothu BK; Gillespie BW; Başer HD; Suwanagool A; Crawford T; Latchamsetty R; Good E; Pelosi F; Bogun F; Morady F; Oral H
Heart Rhythm; 2014 Sep; 11(9):1503-11. PubMed ID: 24813379
[TBL] [Abstract][Full Text] [Related]
15. Cancer-specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO-AF study.
Pastori D; Menichelli D; Bucci T; Violi F; Pignatelli P;
Int J Cancer; 2020 Dec; 147(12):3424-3430. PubMed ID: 32588421
[TBL] [Abstract][Full Text] [Related]
16. Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation.
Pastori D; Pignatelli P; Cribari F; Carnevale R; Saliola M; Violi F; Lip GY
Am Heart J; 2018 Jun; 200():32-36. PubMed ID: 29898846
[TBL] [Abstract][Full Text] [Related]
17. T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
Pastori D; Carnevale R; Stanzione R; Nocella C; Cotugno M; Marchitti S; Bianchi F; Forte M; Valenti V; Biondi-Zoccai G; Schiavon S; Vecchio D; Versaci F; Frati G; Violi F; Volpe M; Pignatelli P; Rubattu S; Sciarretta S
Int J Cardiol; 2021 Jan; 322():245-249. PubMed ID: 32861716
[TBL] [Abstract][Full Text] [Related]
18. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
19. Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Nocella C; Bartimoccia S; Carnevale R; Violi F
Oncotarget; 2016 Jun; 7(26):39143-39147. PubMed ID: 27270651
[TBL] [Abstract][Full Text] [Related]
20. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.
Conen D; Chae CU; Glynn RJ; Tedrow UB; Everett BM; Buring JE; Albert CM
JAMA; 2011 May; 305(20):2080-7. PubMed ID: 21610240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
